Antiviral Agents - Benzazine Derivatives

Overview

Journal Chem Heterocycl Compd (N Y)

Specialty Chemistry

Date 2021 May 19

PMID 34007084

Citations 1

Authors

Nataliya N Mochulskaya

Emiliya V Nosova

Valery N Charushin

Affiliations

Soon will be listed here.

Abstract

The review outlines the results of studies of the antiviral activity of quinoline, quinoxaline, and quinazoline derivatives published over the past 5 years. The supplied data indicate the enormous potential of benzazines for the design of effective antiviral drugs.

Citing Articles

Design, synthesis, studies and apoptotic activity of novel amide enriched 2-(1)- quinazolinone derivatives.

Gariganti N, Bandi A, Gatta K, Pagag J, Guruprasad L, Poola B Heliyon. 2024; 10(9):e30292.

PMID: 38711664 PMC: 11070864. DOI: 10.1016/j.heliyon.2024.e30292.

References

Wang M, Zhang G, Wang Y, Wang J, Zhu M, Cen S . Design, synthesis and anti-influenza A virus activity of novel 2,4-disubstituted quinazoline derivatives. Bioorg Med Chem Lett. 2020; 30(11):127143. DOI: 10.1016/j.bmcl.2020.127143. View

Patel S, Patel B, Pannecouque C, Bhatt H . Design, synthesis and anti-HIV activity of novel quinoxaline derivatives. Eur J Med Chem. 2016; 117:230-40. DOI: 10.1016/j.ejmech.2016.04.019. View

Piotrowska D, Andrei G, Schols D, Snoeck R, Lysakowska M . Synthesis, anti-varicella-zoster virus and anti-cytomegalovirus activity of quinazoline-2,4-diones containing isoxazolidine and phosphonate substructures. Eur J Med Chem. 2016; 126:84-100. PMC: 7125519. DOI: 10.1016/j.ejmech.2016.10.002. View

Boechat F, Sacramento C, Cunha A, Sagrillo F, Nogueira C, Fintelman-Rodrigues N . 1,2,3-Triazolyl-4-oxoquinolines: A feasible beginning for promising chemical structures to inhibit oseltamivir-resistant influenza A and B viruses. Bioorg Med Chem. 2015; 23(24):7777-84. DOI: 10.1016/j.bmc.2015.11.028. View

Shah P, Naik D, Jariwala N, Bhadane D, Kumar S, Kulkarni S . Synthesis of C-2 and C-3 substituted quinolines and their evaluation as anti-HIV-1 agents. Bioorg Chem. 2018; 80:591-601. DOI: 10.1016/j.bioorg.2018.07.016. View

Carta A, Sanna G, Briguglio I, Madeddu S, Vitale G, Piras S . Quinoxaline derivatives as new inhibitors of coxsackievirus B5. Eur J Med Chem. 2018; 145:559-569. DOI: 10.1016/j.ejmech.2017.12.083. View

Desai D, Lauver M, Ostman A, Cruz L, Ferguson K, Jin G . Inhibition of diverse opportunistic viruses by structurally optimized retrograde trafficking inhibitors. Bioorg Med Chem. 2019; 27(9):1795-1803. PMC: 7050290. DOI: 10.1016/j.bmc.2019.03.026. View

Lee J, Tseng C, Lin C, Tseng C . Discovery of novel diarylpyrazolylquinoline derivatives as potent anti-dengue virus agents. Eur J Med Chem. 2017; 141:282-292. DOI: 10.1016/j.ejmech.2017.10.001. View

Hameed A, Abdullah M, Ahmed E, Sharif A, Irfan A, Masood S . Anti-HIV cytotoxicity enzyme inhibition and molecular docking studies of quinoline based chalcones as potential non-nucleoside reverse transcriptase inhibitors (NNRT). Bioorg Chem. 2016; 65:175-82. DOI: 10.1016/j.bioorg.2016.02.008. View

10.

Grabkowska-Druzyc M, Andrei G, Schols D, Snoeck R, Piotrowska D . Isoxazolidine Conjugates of N3-Substituted 6-Bromoquinazolinones-Synthesis, Anti-Varizella-Zoster Virus, and Anti-Cytomegalovirus Activity. Molecules. 2018; 23(8). PMC: 6222691. DOI: 10.3390/molecules23081889. View

11.

Kang D, Zhang H, Zhou Z, Huang B, Naesens L, Zhan P . First discovery of novel 3-hydroxy-quinazoline-2,4(1H,3H)-diones as specific anti-vaccinia and adenovirus agents via 'privileged scaffold' refining approach. Bioorg Med Chem Lett. 2016; 26(21):5182-5186. PMC: 7126219. DOI: 10.1016/j.bmcl.2016.09.071. View

12.

Khan I, Ibrar A, Ahmed W, Saeed A . Synthetic approaches, functionalization and therapeutic potential of quinazoline and quinazolinone skeletons: the advances continue. Eur J Med Chem. 2014; 90:124-69. DOI: 10.1016/j.ejmech.2014.10.084. View

13.

Piotrowska D, Andrei G, Schols D, Snoeck R, Grabkowska-Druzyc M . New Isoxazolidine-Conjugates of Quinazolinones-Synthesis, Antiviral and Cytostatic Activity. Molecules. 2016; 21(7). PMC: 6273226. DOI: 10.3390/molecules21070959. View

14.

Hutterer C, Hamilton S, Steingruber M, Zeittrager I, Bahsi H, Thuma N . The chemical class of quinazoline compounds provides a core structure for the design of anticytomegaloviral kinase inhibitors. Antiviral Res. 2016; 134:130-143. DOI: 10.1016/j.antiviral.2016.08.005. View

15.

Qiu J, Chen W, Zhang Y, Zhou Q, Chen J, Yang L . Assessment of quinazolinone derivatives as novel non-nucleoside hepatitis B virus inhibitors. Eur J Med Chem. 2019; 176:41-49. DOI: 10.1016/j.ejmech.2019.05.014. View

16.

Nobori H, Uemura K, Toba S, Sanaki T, Shishido T, Hall W . Identification of quinolone derivatives as effective anti-Dengue virus agents. Antiviral Res. 2020; 184:104969. DOI: 10.1016/j.antiviral.2020.104969. View

17.

Tariq S, Somakala K, Amir M . Quinoxaline: An insight into the recent pharmacological advances. Eur J Med Chem. 2017; 143:542-557. DOI: 10.1016/j.ejmech.2017.11.064. View

18.

Musharrafieh R, Kitamura N, Hu Y, Wang J . Development of broad-spectrum enterovirus antivirals based on quinoline scaffold. Bioorg Chem. 2020; 101:103981. PMC: 7390679. DOI: 10.1016/j.bioorg.2020.103981. View

19.

Overacker R, Banerjee S, Neuhaus G, Milicevic Sephton S, Herrmann A, Strother J . Biological evaluation of molecules of the azaBINOL class as antiviral agents: Inhibition of HIV-1 RNase H activity by 7-isopropoxy-8-(naphth-1-yl)quinoline. Bioorg Med Chem. 2019; 27(16):3595-3604. DOI: 10.1016/j.bmc.2019.06.044. View

20.

Fabian L, Taverna Porro M, Gomez N, Salvatori M, Turk G, Estrin D . Design, synthesis and biological evaluation of quinoxaline compounds as anti-HIV agents targeting reverse transcriptase enzyme. Eur J Med Chem. 2020; 188:111987. DOI: 10.1016/j.ejmech.2019.111987. View